The Latest Breaking News from biotechnology

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection

Cancer research in the U.S. doesn’t rely on a single institution or funding stream − it’s a complex ecosystem made up of interdependent parts: academia, pharmaceutical companies, biotechnology startups, federal agencies and private foundations. As a cancer biologist who has worked in each of these sectors over the past three…

Cowpea (Vigna unguiculata) is an indigenous and staple crop in sub-Saharan Africa, but it has an enemy: an insect called the legume pod borer (Maruca vitrata). This pest can cause yield losses of more than 80%. The pod borer, originally from south-east Asia, attacks the flowers, pods and seeds.

A final-year BSc student of biotechnology at Veer Bahadur Singh Purvanchal University allegedly committed suicide by hanging herself in her hostel room soon after talking to her fiance over phone

A field known as synthetic biology has become one of the most highly anticipated in science. Its outputs range from golden rice, which is genetically engineered to provide vitamin A, to advances stemming from the Human Genome Project, which successfully mapped the entire human genome. Prominent voices in biotechnology have…

Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.

Public money, private patents: Unravelling India’s opacity over its Covid vaccines

US biotechnology company Colossal Laboratories and Biosciences has a radical proposal: it wants to resurrect the woolly mammoth from extinction. In a preprint paper published on March 4, scientists at Colossal report making a significant step towards this objective. They genetically modified the DNA of mice to give them mammoth-like…

HeLa cells, the world's first immortal human cell line, have played a crucial role in advancing scientific research and biotechnology. Derived from the cervical cancer cells of Henrietta Lacks in 1951, HeLa cells have been indispensable in numerous ...

With positive results from a clinical trial targeting Type 1 diabetes, Wall Street is feeling hot on this little biotech stock.

The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global regulations. Considering the advancements, fundamentally solid biotech stocks Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), and Regeneron Pharmaceuticals (REGN) are emerging as top choices for investors seeking transformative opportunities. Read further….